Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives

Clinical evidence suggests that nebulized colistimethate sodium (CMS) has benefits for treating lower respiratory tract infections caused by multidrug-resistant Gram-negative bacteria (GNB). Colistin is positively charged, while CMS is negatively charged, and both have a high molecular mass and are...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Yinggang Zhu, Antoine Monsel, Jason A. Roberts, Konstantinos Pontikis, Olivier Mimoz, Jordi Rello, Jieming Qu, Jean-Jacques Rouby, on behalf of the European Investigator Network for Nebulized Antibiotics in Ventilator-Associated Pneumonia (ENAVAP)
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	MDPI AG 2021-05-01
Serie:	Microorganisms
Ämnen:	nebulized polymyxin nebulized colistimethate sodium colistin multidrug resistant gram-negative bacteria ventilator-associated pneumonia ventilator-associated tracheobronchitis
Länkar:	https://www.mdpi.com/2076-2607/9/6/1154
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!